EGFR and neoplasm: These common mutant EGFR proteins lead to constitutive activation of downstream extracellular signal-regulated kinase (ERK), phosphoinositide 3-kinase (PI3K)/Akt, and STAT signaling, resulting in ‘oncogene addiction’ and tumor cell growth and survival (Sordella et al, 2004).